https://seekingalpha.com/news/4087599-piper-downgrades-achilles-to-neutral-cites-latest-data?source=feed_sector_healthcare
Apr 05, 2024 - Piper Sandler has downgraded Achilles (ACHL) to neutral in the wake of Phase 1/2 data from its CHIRON and THETIS studies for its precision T cell therapy. Read more here.
0
sa:5805064810207929463
0
https://seekingalpha.com/news/4087581-bristol-myers-2seventy-bio-receive-fda-approval-for-abecma-to-treat-multiple-myeloma?source=feed_sector_healthcare
Apr 05, 2024 - The CAR T therapy Abecma has been approved for adult patients with relapsed or refractory multiple myeloma after two or more prior lines of therapy. Read more here.
0
sa:6059403480014504174
0
https://www.zacks.com/commentary/2251046/top-analyst-reports-for-t-mobile-us-abbott-laboratories-palo-alto-networks?cid=CS-ZC-FT-research_daily-2251046
Apr 05, 2024 - Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW).
zc:-7039653779049094100
0
https://www.zacks.com/stock/news/2251993/the-zacks-analyst-blog-highlights-t-mobile-us-abbott-laboratories-palo-alto-networks-enterprise-products-partners-and-the-pnc-financial-services?cid=CS-ZC-FT-press_releases-2251993
Apr 08, 2024 - T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services are part of the Zacks top Analyst Blog.
zc:-7773365123072611994
0
https://www.zacks.com/stock/news/2254046/t-rowe-trow-upgraded-to-strong-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2254046
Apr 11, 2024 - T. Rowe (TROW) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zc:6577648176333636379
0
https://seekingalpha.com/article/4683831-m-and-t-bank-corporation-mtb-q1-2024-earnings-call-transcript?source=feed_sector_transcripts
Apr 15, 2024 - M&T Bank Corporation (NYSE:NYSE:MTB) Q1 2024 Earnings Call Transcript April 15, 2024 8:00 AM ETCompany ParticipantsBrian Klock - Investor RelationsDaryl...
0
sa:8323167809963609724
0
https://www.zacks.com/stock/news/2255223/m-t-bank-mtb-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2255223
Apr 15, 2024 - The headline numbers for M&T Bank (MTB) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:8814947026667802965
0
https://www.fool.com/investing/2024/04/19/3-top-tech-stocks-to-buy-in-april/?source=iedfolrf0000001
Apr 19, 2024 - AT&T, TSMC, and Palo Alto Networks could head higher throughout the rest of the year.
0
fool:9008506628134591682
0
https://www.zacks.com/stock/news/2258521/t-rowe-price-trow-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2258521
Apr 19, 2024 - T. Rowe (TROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-1526069777174396203
0